
Rineterkib
CAS No. 1715025-32-3
Rineterkib( LTT-462 | ERK-IN-1 )
Catalog No. M26206 CAS No. 1715025-32-3
Rineterkib is an inhibitor of RAF and ERK1/2 activating mutations in the MAPK pathway.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 178 | Get Quote |
![]() ![]() |
10MG | 335 | Get Quote |
![]() ![]() |
25MG | 566 | Get Quote |
![]() ![]() |
50MG | 806 | Get Quote |
![]() ![]() |
100MG | 1098 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameRineterkib
-
NoteResearch use only, not for human use.
-
Brief DescriptionRineterkib is an inhibitor of RAF and ERK1/2 activating mutations in the MAPK pathway.
-
DescriptionRineterkib is an inhibitor of RAF and ERK1/2 activating mutations in the MAPK pathway.(In Vivo):In the Calu-6 human NSCLC subcutaneous tumor xenograft model, Rineterkib (50, 75 mg/kg, p.o.) treatment significantly reduces the tumor volume.
-
In Vitro——
-
In VivoAnimal Model:Calu-6 NSCLC xenograft tumor models in mice.Dosage:50, 75 mg/kg.Administration:Orally either daily (qd) or every other day (q2d) for 27 days.Result:Significantly reduced the tumor volume.
-
SynonymsLTT-462 | ERK-IN-1
-
PathwayApoptosis
-
TargetPERK
-
Recptorβ-adrenoceptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1715025-32-3
-
Formula Weight578.434
-
Molecular FormulaC26H27BrF3N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 200 mg/mL (345.77 mM)
-
SMILESCNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cocker PJ, Lin MY, Tremblay M, Kaur S, Winstanley CA. The β-adrenoceptor blocker propranolol ameliorates compulsive-like gambling behaviour in a rodent slot machine task:implications for iatrogenic gambling disorder. Eur J Neurosci. 2018 Jul 17.
molnova catalog



related products
-
Epieriocalyxin A
Epieriocalyxin A can suppress Caco-2 colon cancer cell growth. It could be a potential drug for colon cancer therapy in the future.
-
6,4'-Dihydroxy-7-met...
6,4'-Dihydroxy-7-methoxyflavanone is a biologically active compound isolated from the heartwood of Dalbergia odorifera T.
-
PERK-IN-4
PERK-IN-4 is a potent and selective PERK inhibitor with an IC50 value of 0.3 nM, used in the study of cancer and neurological disorders.